Pilot study of resveratrol in older adults with impaired glucose tolerance. - Wikidata - wikimedia - TriplyDB

Pilot study of resveratrol in older adults with impaired glucose tolerance.

Pilot study of resveratrol in older adults with impaired glucose tolerance.

http://www.wikidata.org/entity/Q36895103

about

Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence SIRT1 and Kidney Function Challenges in Analyzing the Biological Effects of Resveratrol Modulation of Aromatase by Phytoestrogens Phytochemical Compounds and Protection from Cardiovascular Diseases: A State of the Art An Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of Resveratrol Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans The search for longevity and healthy aging genes: insights from epidemiological studies and samples of long-lived individuals Experimental studies of the molecular pathways regulated by exercise and resveratrol in heart, skeletal muscle and the vasculature How effective are antioxidant supplements in obesity and diabetes?Slowing ageing by design: the rise of NAD(+) and sirtuin-activating compounds Short-term caloric restriction, resveratrol, or combined treatment regimens initiated in late-life alter mitochondrial protein expression profiles in a fiber-type specific manner in aged animals Resveratrol, from experimental data to nutritional evidence: the emergence of a new food ingredient.Resveratrol and cancer: focus on in vivo evidence.Small-molecule allosteric activators of sirtuins.Beneficial and cautionary outcomes of resveratrol supplementation in pregnant nonhuman primates.Recent progress in metabolic signaling pathways regulating aging and life span Minireview: Obesity and breast cancer: a tale of inflammation and dysregulated metabolism Effects of resveratrol on drug- and carcinogen-metabolizing enzymes, implications for cancer prevention.Gene-Diet Interactions in Type 2 Diabetes: The Chicken and Egg Debate An examination of resveratrol's mechanisms of action in human tissue: impact of a single dose in vivo and dose responses in skeletal muscle ex vivo.Targeting sirtuins for the treatment of diabetes Role of bioactive food components in diabetes prevention: effects on Beta-cell function and preservation.Plant-Derived Compounds Targeting Pancreatic Beta Cells for the Treatment of Diabetes.The flavones apigenin and luteolin induce FOXO1 translocation but inhibit gluconeogenic and lipogenic gene expression in human cells.Safety and metabolic outcomes of resveratrol supplementation in older adults: results of a twelve-week, placebo-controlled pilot study.SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective.Resveratrol in metabolic health: an overview of the current evidence and perspectives.Targeting mitochondrial alterations to prevent type 2 diabetes--evidence from studies of dietary redox-active compounds.Pharmacologic Means of Extending Lifespan.Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases.A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones.Molecular strategies for targeting antioxidants to mitochondria: therapeutic implications.Resveratrol ameliorates the maturation process of β-cell-like cells obtained from an optimized differentiation protocol of human embryonic stem cells Resveratrol Improved Flow-Mediated Outward Arterial Remodeling in Ovariectomized Rats with Hypertrophic Effect at High Dose.The journey of resveratrol from yeast to human.Differential modulation of nitric oxide synthases in aging: therapeutic opportunities.The effect of resveratrol on longevity across species: a meta-analysis Resveratrol as a calorie restriction mimetic: therapeutic implications.

P2860

Q24618313-570AB0C6-5E02-4C66-A75A-CFCD82050AC4 Q26740442-782C971F-7769-420E-A9C4-5CCC5CC3E3A6 Q26746257-F97182A3-1048-41F6-943C-1959B7589A83 Q26769876-CD12DD08-DDF4-4DC4-9AA0-C7B68BBB5173 Q26778562-34A69101-0A1C-4F12-8C19-484B4D2FDD71 Q26800907-6820A0BF-6A6E-4FDD-949F-EFB971CC924F Q26801926-EE6F3778-7C45-4DA3-924F-99F3DD9601CB Q27013823-2AF2F6BC-C82D-45BA-A991-5E9682419794 Q27016095-D430A022-DBC0-4FBC-B722-A3611C825AE0 Q28087696-FE6006B8-F277-47FB-BC6B-95EF4E209EAA Q28314993-B59A5FDB-4F9F-465B-8ED7-5C22CDA4D682 Q28566837-BEF244E4-53C9-4061-A387-D049903FEA54 Q30655313-01E944D0-5EE5-4A02-8CA6-909D82512F9E Q33578943-E4A11281-6784-49B6-9F28-10629941B420 Q33601236-28335FD3-C573-4651-BD98-BC4B0C89EA88 Q33613239-536530CB-C504-489D-9059-AB8FB058EE3B Q33616159-BF9A65AA-79FB-4090-B459-240E75A3F1C7 Q33635798-073965BB-B1A6-4AE3-BFB1-6283FC77D0B1 Q33771427-3496D279-9C26-436F-9469-E118D93BA62B Q33838645-83E746FB-5259-4354-B3D3-AFE2288DEB16 Q33897333-7539A0DC-B49A-418F-B711-8CA0AC81414E Q33946771-E41DC266-F5CB-4856-AC1B-1872C8B9D989 Q33976239-E3CC65BA-44ED-4A02-A14D-BA178EC55A09 Q34045439-995D222A-D604-41C2-8781-0FCB507068F0 Q34066395-56AB4732-C7D3-4332-A943-84CC07533E0D Q34112051-90892E1E-9F7C-4DB3-8734-8E9242BCC8F8 Q34272924-4F22D538-5B28-41DA-A0E4-FD1C90E21A36 Q34357562-5AFA63BC-B78D-4ED1-942C-C1E53595CB82 Q34357570-38B6D526-3F4A-4188-A010-98FFD0A6DE83 Q34412057-BF4D09EC-88B0-4D9F-BA7B-05602D5EAA2D Q34449372-B55FFE3D-7B90-47AE-A6EA-386AB4B13892 Q34538482-57D17682-46D8-488A-9D47-D6FDE24B580D Q34570111-3FE89F05-3D90-4768-9FB0-F0D7F82E3193 Q35148462-2F1307F0-EBFE-4F52-900B-AC78DEB1DEC2 Q35182244-A23B903A-3E95-44FB-B423-C99684585DEA Q35886504-67BDC4B3-7A97-403E-95E9-8D4ADF366287 Q35947372-19580167-FEC6-4C31-8127-1E8B968DDA34 Q36056243-0EDCFDA6-804B-42B1-8E9B-44668DBE0595 Q36231345-BF13208A-9D7F-49B5-ADFD-BD0A236447ED Q36291200-0E77D4A2-42F7-43D0-802C-452341245F6A

P2860

Pilot study of resveratrol in older adults with impaired glucose tolerance.

http://www.wikidata.org/entity/Q36895103

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Pilot study of resveratrol in older adults with impaired glucose tolerance.

@en

type

label

Pilot study of resveratrol in older adults with impaired glucose tolerance.

@en

prefLabel

Pilot study of resveratrol in older adults with impaired glucose tolerance.

@en

P1433

Q36895103-0C40B825-C783-4B44-A5C4-DC7CDF596240

P1476

Q36895103-E124321B-11CB-4202-98CD-DDBC3C113C46

P2093

Q36895103-0578A818-C432-4FBB-B37E-1DBD5580CC67

Q36895103-36325E11-91F3-43BE-9D1D-E3CA75DD3AB3

Q36895103-86CE898A-9157-496E-825D-A464DF5A0795

Q36895103-AEE4B22D-4B9B-42DD-95D2-3A5916115B30

Q36895103-D6611CEA-CA56-4228-88D6-9C53BB3B5C5E

Q36895103-F695413A-F081-4A80-9285-FDE6D94271EB

P2860

Q36895103-12CE2C4D-2879-43EF-A9EC-E2D6EBC1A375

Q36895103-14F6879F-83A9-46F6-8AF0-2EF779D56C62

Q36895103-1D3FC0D2-4869-46BF-911D-973B1E0EC7B2

Q36895103-2536BD0A-6A2B-4757-972F-79EE64C61344

Q36895103-3015799A-CD78-460D-922D-AE99D19BFE85

Q36895103-3306B4B3-A153-4B4D-BDA4-FE31009C3BCF

Q36895103-4613ACA9-4618-4E9C-B070-9FA57B37890E

Q36895103-49FE3C35-78AB-4150-9DC7-E0BF805AE063

Q36895103-4EC1399D-0477-4A0F-9D42-A07F359E47D5

Q36895103-5AC0C912-8931-448B-85C0-D11590F50832

P304

Q36895103-C0E3E5FC-A9C1-4F19-B518-A08A14B344AA

P31

Q36895103-95994EDF-1287-4CB7-854C-13B7CE1CEEAB

P356

Q36895103-23313DC3-72D5-4FF4-8F1D-73AFD4C3CEB2

P407

Q36895103-24B924C0-B69E-4CD0-B4F0-BCCAFA874E12

P433

Q36895103-6628E8A3-765E-4D85-A37A-4AAE04A98FAF

P478

Q36895103-33C99F0C-F25A-44CC-904C-9680A1499113

P50

Q36895103-26EFB131-A958-4551-971A-623D0D867B19

Q36895103-E83FD74C-CAF6-403E-8642-A4E0994CFBFF

P577

Q36895103-5DB2D352-76D3-4ED7-81BD-1E4F246436E3

P5875

Q36895103-05702219-D230-40D4-B95B-DF623D318251

P698

Q36895103-E178CA8E-1BA6-4047-9CC9-661FA0B84754

P932

Q36895103-E4B35C30-0057-4BAC-BD04-DF4C50EF3622

P356

P1433

The Journals of Gerontology

P1476

Pilot study of resveratrol in older adults with impaired glucose tolerance

@en

P2093

Georgeta Trandafirescu

http://www.w3.org/2001/XMLSchema#string

Jill P Crandall

http://www.w3.org/2001/XMLSchema#string

Meredith Hawkins

http://www.w3.org/2001/XMLSchema#string

Migdalia Reid

http://www.w3.org/2001/XMLSchema#string

Nir Barzilai

http://www.w3.org/2001/XMLSchema#string

Preeti Kishore

http://www.w3.org/2001/XMLSchema#string

P2860

A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice

SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1

Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes

Resveratrol improves health and survival of mice on a high-calorie diet

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

Resveratrol is a selective human cytochrome P450 1A1 inhibitor

Therapeutic potential of resveratrol: the in vivo evidence

Sirtuins in mammals: insights into their biological function

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.

AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol

P304

1307-1312

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/GERONA/GLR235

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

67

http://www.w3.org/2001/XMLSchema#string

P50

Hillel W. Cohen

P577

2012-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51984204

http://www.w3.org/2001/XMLSchema#string

P698

22219517

http://www.w3.org/2001/XMLSchema#string

P932

3670158

http://www.w3.org/2001/XMLSchema#string